Rochester Medical Corporation One Rochester Medical Drive Stewartville,
MN 55976-1647 United States - Map Phone: 507-533-9600 Fax: 507-533-9725 Website: http://www.rocm.com
Rochester Medical Corporation engages in the development, manufacture, and marketing of PVC-free and latex-free urinary continence and urine drainage care products for the home and acute care markets. Its home care products include silicone male external catheters (MECs) under the UltraFlex, Pop-On, Wide Band, Natural, Clear Advantage, Transfix, and Spirit names for managing male urinary incontinence; latex MECs under the Freedom and Freedom Plus names for managing male urinary incontinence; intermittent catheters, such as standard, antibacterial, hydrophilic, and antibacterial personal catheters in various diameters for male, female, and pediatric use; and the FemSoft Insert, a liquid-filled urethral insert for managing stress urinary incontinence in adult females. The companys acute care products comprise standard and StrataSI silicone Foley catheters, as well as StrataNF catheter, an antibacterial Foley catheter that reduces the incidence of hospital acquired urinary tract infection. It also distributes ostomy, and wound and scar care products and accessories; anti-decubitis mattresses; and other branded urological products. Rochester Medical Corporation offers its products to distributors, individual hospitals, healthcare institutions, and extended care facilities. The company markets its products primarily under the Rochester Medical brand name through a direct sales force in the United States, the United Kingdom, and the Netherlands; and supplies to various medical product companies and group purchasing organizations, as well as markets through independent distributors in other international markets. Rochester Medical Corporation was founded in 1988 and is headquartered in Stewartville, Minnesota. Key Statistics
| |
| Rochester Medical Corporation’s ISS Governance QuickScore as of May 1, 2013 is 8. The pillar scores are Audit: 10; Board: 10; Shareholder Rights: 1; Compensation: 7. | | Brought to you by Institutional Shareholder Services (ISS) |
| | Pay | Exercised | Mr. Anthony J. Conway ,
69 Co-Founder, Exec. Chairman, Chief Exec. Officer and Pres | 436.00K | 142.00K | Mr. Philip J. Conway ,
57 Co-Founder and VP of Production Technologies | 260.00K | 0.00 | Mr. David A. Jonas ,
49 Chief Financial Officer, Chief Accounting Officer, Sec., Treasurer and Director | 302.00K | 0.00 | Mr. James M. Carper ,
62 VP of Sales and Marketing | 250.00K | 0.00 | Mr. Martyn R. Sholtis ,
54 Corp. VP | 282.00K | 0.00 |
|
| | Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|